Quick Answer
PURE BIOSCIENCE, INC. reported Revenue From Contract With Customer Excluding Assessed Tax of $2.20 million for the year ending 2025.
- PURE BIOSCIENCE, INC. showed an increase of +12.2% in Revenue From Contract With Customer Excluding Assessed Tax from 2024 to 2025.
- This data is from PURE BIOSCIENCE, INC.'s annual report (Form 10-K), filed with the SEC on October 29, 2025.
- XBRL data for this metric is available from 2017 to 2025 (9 years of filings). Earlier data may not exist in machine-readable XBRL format as companies adopted electronic filing at different times.
- Quarterly values from 10-Q filings: Q4 2017: $464.0 thousand | Q1 2018: $411.0 thousand | Q2 2018: $390.0 thousand | Q4 2018: $590.0 thousand | Q1 2019: $394.0 thousand | Q2 2019: $312.0 thousand | Q4 2019: $398.0 thousand | Q1 2020: $349.0 thousand | Q2 2020: $2.22 million | Q4 2020: $1.59 million | Q1 2021: $916.0 thousand | Q2 2021: $561.0 thousand | Q4 2021: $501.0 thousand | Q1 2022: $416.0 thousand | Q2 2022: $524.0 thousand | Q4 2022: $471.0 thousand | Q1 2023: $397.0 thousand | Q2 2023: $407.0 thousand | Q4 2023: $722.0 thousand | Q1 2024: $326.0 thousand | Q2 2024: $441.0 thousand | Q4 2024: $556.0 thousand | Q1 2025: $391.0 thousand | Q2 2025: $491.0 thousand | Q4 2025: $708.0 thousand | Q1 2026: $444.0 thousand.
- Over the full 9 years of available data (2017 to 2025), PURE BIOSCIENCE, INC.'s Revenue From Contract With Customer Excluding Assessed Tax has grown by 20.3%.
- Historical annual values: Fiscal year 2025: $2.20 million | Fiscal year 2024: $1.96 million | Fiscal year 2023: $1.88 million | Fiscal year 2022: $1.85 million | Fiscal year 2021: $3.93 million | Fiscal year 2020: $6.92 million | Fiscal year 2019: $1.91 million | Fiscal year 2018: $1.77 million | Fiscal year 2017: $1.83 million.
- Data sourced from SEC EDGAR public filings as of August 10, 2026.
Last verified: